throbber
Clin. exp. Immunol. (1988) 71, 508-516
`
`Production of heavy-chain class-switch variants of human
`monoclonal antibody by recombinant DNA technology
`
`SHINJI KOMORI, NORIYUKI YAMASAKI, MINORU SHIGETA*, SHINZO lSOJIMA* & TAKESHI
`WATANABE Department of Molecular Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, and
`* Department of Obstetrics and Gynecology, Hyogo Medical College, Hyogo, Japan
`
`(Acceptedfor publication 22 September 1987)
`
`SUMMARY
`
`We have previously established a human—mouse heterohybridoma (H6-3C4), which produced a
`human sperm-immobilizing antibody ()1, A of human type). The human rearranged immunoglobulin
`it-chain and ).-chain genes were cloned from the hybridoma H6-3C4. The cloned V region of the
`heavy chain (VH) gene was ligated to human immunoglobulin y,-heavy chain constant region (Cyl)
`genes. This resulted in the heavy-chain class-switch from p-chain to yl-chain of H6-3C4 antibody.
`The class-switched heavy-chain gene as well as the cloned /l-chain gene were introduced into mouse
`myeloma cell line X63Ag8.653 by protoplast fusion and electroporation. The stable transformants
`produced the human IgG monoclonal antibody, which fully retained specificity to human spemi cells
`and sperm-immobilizing activity.
`
`recombinant DNA technology heavy chain class-switch
`Monoclonal antibody
`Keywords
`anti-spenn antibody sperm immobilization
`
`INTRODUCTION
`
`lmmunoglobulin molecules are encoded by three unlinked gene
`families, two light chain genes, kappa(i<) and lambda(A), and a
`heavy chain gene. Each chain is composed of variable (V) region
`and constant (C) region. The V region of the heavy chain (VH) is
`encoded by three distinct gene segments; VH, DH(diversity) and
`JH(ioining). The C region of heavy chain (CH) is encoded by Cp,
`C6, Cy, Ca and Ca. During B cell development, these gene
`segments are brought together to form a complete immunoglo-
`bulin gene (Tonegawa, 1983). Recently, novel antibody mole-
`cules, which are composed of a mouse V region and a human C
`region, have been constructed. They retained the antigen
`specificity of the original mouse antibodies(Morrison et al.,
`1984; Boulianne, Hozumi & Shulman, 1984; Neuberger et al.,
`1985; Sahagan et al., 1986; Nishimura et al., 1987). In these
`cases, a V” and/or a V._ gene was cloned from the mouse
`hybridoma cells which secreted a useful monoclonal antibody.
`The cloned mouse VH and/or V,_ gene was then ligated to a
`human constant region gene by the recombinant DNA tech-
`nique. Since the V region gene can be joined to any C region gene
`by this technique, it is possible to replace a C region gene with
`
`Correspondence: Takeshi Watanabe, Department of Molecular
`Immunology, Medical Institute of Bioregulation, Kyushu University,
`Maidashi 3-l-1, Higashi-ku, Fukuoka 812, Japan.
`
`any other C gene of appropriate heavy chain isotype to obtain
`the desired biological effect or function.
`We have previously established a human—mouse heterohy-
`bridoma, which produced a human IgM class antibody to
`human-sperm-coating antigen (Isojima et al., 1987). However,
`most of the naturally-occuring antibodies to human sperm anti-
`gens belong to the IgG class and exhibit the immobilization of
`spenn in vaginal exudates, which may result in sterility (Isojima,
`Li & Ashitaka, 1968). In human—mouse heterohybridomas,
`human chromosomes carrying immunoglobulin genes may
`often be lost from the hybrid cells during culture. To stabilize the
`genes coding for antibody molecules to human sperm antigen
`and to make IgG class monoclonal antibodies, the immuno-
`globulin genes were cloned from the heterohybridomas and
`human monoclonal IgM class antibody was class-switched to
`IgG by recombinant DNA technology. In the present study, we
`have isolated the human rearranged immunoglobulin [1 and A
`genes from the human—mouse heterohybridoma (H6-3C4),
`which produced a human antibody to human-sperm-coating
`antigen. The H6-3C4 monoclonal antibody could immobilize
`human sperm in the presence of complement (Isojima et al.,
`1987). The V region gene of the cloned H6-3C4 it-heavy chain
`gene was joined to the human Cy. region gene, which had been
`cloned from the human plasma cell leukaemia line, ARH-77
`(Kudo et al., 1985). The reconstructed genes contained a human
`heavy-chain enhancer region DNA in J-C intron as a heavy
`chain gene-expression control element (Gillies et al., 1983;
`
`Genzyme Ex. 1043, pg 950
`
`Genzyme Ex. 1043, pg 950
`
`

`
`A class—switched recombinant monoclonal antibody
`
`-kflndlfl
`\Ps’tI
`|—+—+—I———+-I-Iv—I——iII+—t——|
`
`\BamHI/Pstl
`
`-_.
`-.0
`
`Qm
`
`I" <L
`
`OF
`
`l—-4
`tkbp
`
`Fig. 1. Restriction map of DNA clones of 3C4VH and 3C4L2. Closed boxes indicate exons. the clone 3C4V“ is 8-2 kb in length and
`contains a functional rearranged V region gene. The clone 3C4L2 is 5-6 kb in length and contains functional rearranged V). and C}.
`genes. L, leader sequence; V, variable region; D, diversity segment; J, joining segment; C, constant region.
`
`Banerji, Olson & Schaffner, 1983; Queen & Baltimore, 1983).
`The cloned H6-3C4 A-light chain gene was also joined to the
`human heavy chain enhancer region DNA as a light chain gene-
`expression control element. This novel heavy chain gene was
`integrated into the pSV2gpt vector and transfected into the
`mouse myeloma cell line, X63Ag8.653. The resultant stable
`transfoimants, which produced human y-heavy chain, were
`then transfected with the A-chain gene derived from the H6-3C4
`hybridoma. The stable transfonnants ‘obtained after selection
`produced human IgG molecules (vi, 1), which showed human-
`sperrn-immobilizing activity.
`
`MATERIALS AND METHODS
`
`Southern blot analysis
`DNA was digested by restriction enzymes, electrophoresed on a
`0-7% agarose gel and blotted onto nitrocellulose filters. The
`
`filter was hybridized with "P-labelled DNA probes overnight at
`65°C in 10 x Denhardt’s solution, 1 M NaCl, 10 mM EDTA, 50
`mM Tris HC1 (pH 7-4) and 01% SDS. After hybridization, the
`filter was washed with 2 x SSC and 0- l % SDS at
`room
`temperature for 10 min, and with 0-1 X SSC and 0‘l°/0 SDS at
`65°C for 10 min before autoradiography.
`
`Genomic cloning
`High molecular weight DNA was prepared from the human-
`mouse heterohybridoma H6-3C4, which produced a human-
`sperm-immobilizing antibody (Isojima et al., 1987). The DNA
`was digested with Hindlll endonuclease and size-fractionated
`by a sucrose density gradient. Centrifugation was carried out at
`100,000 g for 16 h at 15°C. The DNA fractions in 8-10 kb size
`(containing heavy chain genes) and 5-6 kb size (containing light
`chain genes) were respectively ligated into 1 phage Charon 28.
`
`Genzyme Ex. 1043, pg 951
`
`Genzyme Ex. 1043, pg 951
`
`

`
`Shinji Komori et al.
`
`GGGTTTGGTGAGGGGAGGCCACAGGAAGAGAACTGAGTTCTCAGAGGGCA-CAGCAGCATACACCTCCCA
`ii_iiiiIt-i¢*i_fittitittiiiiiiiitGTtiiiiti*ii__-*icAficttiiiiiiit*iitit
`
`GGGTGAGCCCAAAAGACT-GGGGCCTCCCTCCATCCCTTTTTACCTATCCATACAAAGGCACCACCCACA
`iiiiiiiitfiifiiitiitciiiitiiiifii_ifititiitititiiiciiii*fi*i**iifiiiififitii?
`
`70
`
`140
`
`210
`
`TGCAAATCCTCACTTAGGCACCCACAGGAAATGACTACACATTTCCTTAAATTCAGGGTCCAGCTCACAT
`T«l'IT~l1T*tatit1:1--kt-kmtatatat1:atan:atat1:at1:-kt-I:-kTi'7l1'-Ea****~A-at-aA*******-A:-k-kit-:1-111-‘F
`
`Leader
`‘I9
`L
`L
`F
`F
`L
`H
`H
`K
`M
`GGGAAGTGCTTTCTGAGAGTCATGGACCTCCTGCACAAGAACATGAAACACCTGTGGTTCTTCCTCCTCC
`iifiticiiiitii-i*iitit*i**iiii*t*iiiiiiiiitiiitiittiitiiiiitciiiiiiii_
`
`280
`
`R
`P
`A
`A
`V
`L
`TGGTGGCAGCTCCCAGATGTGAGTGTCTCAGGAATGCGGATATGAAGATATGAGATGCTGCCTCTGATCC
`iiiiiriiiiiiiiiiiiifiiittiiiiiiCCiiifiitttitttfittttiiifififififliififitiitttit
`
`350
`
`'4—Leader
`
`H V
`CAGGGCTCACTGTGGGTTTCTCTATTCACAGGGGT --------------------------------- --
`***********************G***********AGTGTCTCACCAATGCGGATATGAAGATATGAGAT
`
`420
`
`Leader
`
`v
`
`V reg1’on_
`
`0490
`L
`0
`V
`0
`S
`L
`----------------------------------------------- --CCTGTCCCAGGTGCAGCTACA
`GCTGCCTCTGATCCCAAGGCTCACTGTGGGTTTCTCTGTTCACAGGGGT*********************
`
`S 560
`G
`6
`Y
`V
`D
`C
`T
`L
`S
`L
`T
`E
`S
`P
`K
`L
`L
`G
`A
`G
`N
`Q
`GCAGTGGGGCGCAGGACTGTTGAAGCCTTCGGAGACCCTGTCCCTCACTTGCGATGTCTATGGTGGGTCC
`ciifiiiiiiiiftiiiiii-it*iiiiiiiiitiitiiiitttttiticiiticiiiiiTii**ftfiii
`
`I 630
`E
`G
`I
`H
`E
`L
`G
`K
`G
`P
`P
`Q
`R
`I
`H
`S
`H
`Y
`Y
`G
`S
`F
`TTCAGTGGTTACTACTGGAGTTGGATCCGCCAGCCCCCAGGGAAGGGG-CTGGAGTGGATTGGGGAAATC
`iiiiittiitiiiiiittiiciffiiitit*tti*i*iittiiiitiffA*ii*tiiiitii*fiAt*ii*i
`
`S700
`T
`D
`V
`S
`I
`T
`V
`R
`S
`R
`L
`S
`P
`N
`Y
`N
`T
`S
`G
`S
`H
`N
`AATCATAGTGGAAGCACCAACTACAACCCGTCCCTCAGGAGTCGA--GTCACCATATCAGTAGACACGTC
`**ii**ti*ittiiii****Tiit*tAA*tt****iiAtii**i*TA*iiii*it**iTT*iiiii#*i*
`
`— —— ———
`
`V region
`
`R 770
`A
`C
`Y
`Y
`V
`A
`T
`D
`A
`A
`T
`V
`S
`R
`L
`K
`L
`S
`F
`0
`N
`K
`CAAGAATCAGTTCTCCCTGAAGCTGAGGTCTGTGACCGCCGCGGACACGGCTGTGTATTACTGTGCGAGA
`iiiiiiciTi*i*ii*iitiiififii*iCiiiiitiitiiiiitiiiiiiiiitfiieiiiiitiiiiiite
`+98
`D reg1'on___jT1°8___:_:J5 region
`Y 840
`G
`L
`V
`M
`F
`6
`R
`G
`I
`M
`H
`N
`Y
`Y
`Y
`M
`D
`V
`H
`G
`GGCTTTAT--GGTTCGG--GGAATTATGTGGAACTACTACTAC---ATGGACGTCTGGGGCAAAGGGACC
`iiiciccicc**GGGi*cTit*tcG*cii*i*-*ifi**t*tiTGGT***ttii*ttit*i*c****tit*
`+124
`
`P
`S
`V
`Y
`V
`Y
`3C4 ACGGTCACCGTCTCCCCAGGTAGGAATGGCCACTTCTAGGGCCTTTGTTTTGTGCAACTGCCTGTGGGGT
`H16 itiiiifitiiitiiiTfi*i****ti*iiii****-itif**it*it*tfiiic§i*TC***T*tticiA*i
`
`910
`
`Fig. 2. Nucleotide sequences and predicted amino acid sequences of the V region of H6-3C4 monoclonal antibody. (a) Nucleotide
`sequences and predicted amino acid sequences of the V region of 3C4VH gene and HIGI gene. HIGI gene was isolated from a human
`plasmacytoma cell line, ARH-77 (Kudo et al., 1985). The V region gene of 3C4VH showed high homology with that of HIGI gene.
`"‘3C4VH gene was identical to HIG1 gene. Dashed lines show deletion. (b) Nucleotide sequences and predicted amino acid sequences of
`3C4VL. The C region of 3C4L2 gene is not shown. But according to the nucleotide sequence, the C region of 3C4L2 was identical to
`germline C/12. Amino acid residues are designated by one letter code.
`
`Genzyme Ex. 1043, pg 952
`
`Genzyme Ex. 1043, pg 952
`
`

`
`A class-switched recombinant monoclonal antibody
`
`511
`
`After packaging, the resulting recombinant phage libraries were
`screened with the “P-labelled human JH probe or with the "P-
`labelled human C12 probe.
`
`Nucleotide sequences
`Selected phage DNA molecules were recloned into pBR322
`vectors and subcloned into the M13 phage vectors, mp18 and
`mpl9. They were sequenced by dideoxy chain termination
`methods (Sanger, Nichklen & Coulson, 1977).
`
`Construction of recombinant lg genes
`A recombinant heavy chain gene was constructed by ligating the
`V“ gene of the H6-3C4 hybridoma to the human Cy. gene, which
`had been isolated from the ARH-77 cells (Kudo et al., 1985). A
`human heavy chain enhancer region (Mlul-Hpal fragment) was
`contained in the C32, gene fragment (Mlul-BamHI) (Fig. 3a). A
`human heavy chain gene enhancer was also ligated upstream of
`
`the cloned /'.-light chain gene as shown in Fig. 3b. The
`recombinant heavy chain gene (ECoRI-BamHI fragment, 15
`kb) was inserted into the EcoRI and BamHI sites of pSV2gpt
`vector (Mulligan & Berg, 1981) (pSV2-SIGl). Through linker
`conversion, the recombinant light chain gene was inserted into
`the EcoRI site of pSV2neo vector (Southern & Berg, 1982)
`(pSV2-SI-A-E).
`
`DNA transfection
`Protoplast fusion (Sandri-Goldin, Goldin & Levine, 1982) and
`electroporation (Potter, Weir & Leder, 1984) were used to
`transfect the recombinant immunoglobulin genes (pSV2-SIGI,
`pSV2-SI-AE) into the mouse myeloma cells, X63Ag8.653 (Kear-
`ney et al., 1979). At first, the pSV2-SlG1 was transfected into
`X63Ag8.653 cells by protoplast fusion. The stable transfor-
`mants selected with mycophenolic acid (Lilly Co., Ltd) (Mulli-
`gan & Berg, 1981). The human y.-heavy chain-producing
`
`(b)
`
`ATCTTGAGAAATTACTCAGAGAAGGCCATCAGGCTCAGGGCTCAGACAAGAACCAGGACAAATGTTTTAG
`
`GGAATGGAGAACAGATTTGCATCCACTGCTCACCAGAGCCACCTAACGACGACACAAGAATAAAGGAAGT
`
`70
`
`140
`
`210
`
`AGATTTGCATGAAGAGACTTCCCTTCCTATGATAAGAGAGGCCTGGAGGTTCCTCCTTAGCTGTGGGCTC
`
`-19
`
`Leader
`
`MAHTPLHLTLFTL280
`AGAAGCAGAGTTCTGGGGTGTCTCCACACCATGGCCTGGACCCCTCTCTGGCTCACTCTCTTCACTCTTT
`
`-5
`
`C
`
`I
`
`GCATAGGTGCTGCCTCCCAGGGCTCAACCCCATATTATCATGCTAGCTGTGCCAACCTGGCCCCGAGCTT
`
`350
`
`420
`
`CGGCTCAACACAGGGAGTAGTGTAGGGTGTGGGACTCTAGGCGTGAAACCCTTATCCTCACCTCTTCTGT
`
`'4__Leader__*1
`
`V region
`
`GSVVSSEL
`QDPVVSVAL G
`0490
`CCTCTTTTGCAGGTTCTGTGGTTTCTTCTGAACTGACTCAGGACCCTGTTGTGTCTGTGGCCTTGGGACA
`TVRI TCQGDSLR TYHASHYQQKP560
`GACAGTCAGGATCACATGCCAAGGAGACAGCCTCAGAACCTATCATGCAAGCTGGTACCAGCAGAAGCCA
`
`RQAPVLVIYDEN RPSQIPDRFS630
`AGACAGGCCCCTGTACTTGTCATCTATGATGAAAACAACCGGCCCTCAGGGATCCCAGACCGATTCTCTG
`
`GSTSGNTASLTI TGAQAEDE A
`Y Y700
`D
`GCTCCACCTCAGGAAACACAGCTTCCTTGACCATCACTGGGGCTCAGGCGGAAGATGAGGCTGACTATTA
`
`V region___..__*'97
`
`J region
`
`‘I03
`
`CNSRDSSGNRLV
`FGGGTKLTVL 770
`CTGTAACTCCCGGGACAGCAGTGGTAACCGTCTGGTATTCGGCGGAGGGACCAAGCTGACCGTCCTAGGT
`
`GAGTCTCTTCTCCCCTCTCCTTCCCCACTCTTGGGACAATTTCTGCTGTTTTTGTTTGTTTCTGTATCTT
`
`840
`
`Fig. 2 (continued)
`
`Genzyme Ex. 1043, pg 953
`
`Genzyme Ex. 1043, pg 953
`
`

`
`Shinji Komori et al.
`
`HIG 1 (ARH77)
`
`(b) Human
`Enhancer
`
`klenow fragment
`4/
`EcoR I linker
`
`Amp’
`
`co—neo
`
`$V400f'l
`
`DBR322
`ori
`
`pSV2—S|G1
`
`Eco-opt
`
`pBR322
`orl
`
`$V40orI
`
`Fig. 3. Structure ofplasmids (a) pSV2-SlGl and (b) pSV2-Slit-E. V, variable region; D, diversity segment; J, joining segment; C, contrast
`region; En, human heavy chain enhancer. (a) The plasmid pSV2-SlGl contains the class-switched heavy chain gene. (b) The plasmid
`pSV2-SI}.-E contains the cloned 3C4L2 gene, which was ligated with a human heavy chain enhancer region. Open boxes indicate exon.
`
`transformants of X63Ag8.653 cells were transfected with the
`pSV2-SI-AE by electroporation, and G418 antibiotics (Gibco
`Laboratories) (1-0 mg/ml) were used for selection (Southern &
`Berg, 1982).
`
`Sperm immobilization test
`A modified micro-sperm immobilization test was used (Isojima
`& Koyama, 1979). Briefly, 10 ,ul of culture supernatants were
`added into each well of Terasaki plate (Falcon, No.3034) and
`the liquid parrafin oil was overlayered. Two microlitres of
`pooled guinea pig serum as complement source and 1 pl of active
`human spermatozoa suspension (2 X 107/ml) were added to the
`supernatants and incubated at 37°C for 60 min. As a comple-
`ment control, 2 pl of heat-inactivated (56°C, 30 min) guinea pig
`serum was used. The S1 titre of the antibodies was calculated as
`
`50% sperm immobilization unit (S150) (Isojima & Koyoma,
`1976).
`
`Immunoblot analysis
`The supernatants (10 al) of the transformants were electrophor-
`esed on a NaDodSO4/polyacrylamide gel
`in the reduced or
`nonreduced condition. Protein bands were transferred to nitro-
`
`cellulose filters by a Bio Rad transblot cell apparatus. To
`minimize the background,
`the filters were treated with a
`masking solution (1% BSA, 01% NaN3 and 0-05% Tween 20)
`for 60 min. Peroxidase-conjugated goat anti-human IgG (y.-
`specific) was diluted in a masking solution (111000) and added to
`the filters. They were incubated for 60 min at room temperature.
`After washing three times in TBS (50 mM Tris HCl (pH 7-5) and
`200 mM NaCl), the visual signal was produced by a substrate
`solution (4-chloro-1-naphthol/methanol and H202) for a few
`minutes at room temperature. To detect }.-light chain, rabbit
`anti-human }.-light chain sera (Miles laboratories Inc. USA)
`were diluted in a masking solution (1:l000) and added to the
`filters. They were incubated for 60 min at room temperature.
`After washing the filters in TBS, peroxidase-conjugated goat
`anti-rabbit IgG (ZYMED laboratories Inc, USA), which was
`diluted in a masking solution (l:l000), was added to the filters.
`They were incubated for 60 min at room temperature. Then the
`same substrate solution was added.
`
`RNA preparation and Northern blot analysis
`Total RNA was extracted from H6-3C4, NS1 or stable transfor-
`mants. RNA (10 pg) was electrophoresed on a 0-75% formalde-
`
`Genzyme Ex. 1043, pg 954
`
`Genzyme Ex. 1043, pg 954
`
`

`
`A class-switched recombinant monoclonal antibody
`
`51
`
`hyde agarose gel, blotted to nitrocellulose filters and hybridized
`with the nick-translated "P-labelled cloned human VH or V;
`gene.
`
`RESULTS
`
`Isolation of H6-3C4 heavy and light chain genes
`Southern blot analysis of the heavy chain genes of the H6-3C4
`hybridoma showed that a rearranged heavy-chain gene was
`contained in 8 kb fragments of HindIII-digested DNA and a
`rearranged light-chain gene was in 5-6 kb fragments of HindIII-
`digested DNA (data not shown)
`A genomic library was constructed as described in Materials
`and Methods. After screening with a human JH (JH3—6) DNA
`probe or with a human C12 DNA probe, one positive clone for a
`heavy chain gene (3C4VH) and two positive clones for a light
`chain gene (3C4L2) were isolated. The clone 3C4VH contained a
`rearranged human heavy chain variable region (VDJ) gene and
`was 8.2 kb long. The clone 3C4L2 contained a rearranged
`human light chain variable region (VJ) gene and a C 1 gene, and
`was 5.6 kb long. The restriction enzyme maps of the both clones,
`3C4VH and 3C4L2, are shown in Fig. 1.
`
`Nucleotide sequences of the 3C4 VH and 3C4L2 genes
`As shown in Fig. 2a, the nucleotide sequences of the V region of
`the 3C4VH gene were highly homologous to that of the HIG1
`gene, which had been isolated from a human IgGl-secreting
`plasmacytoma cell line, ARH-77, and reported by us previously
`
`(Kudo et al., 1985). The V region of the 3C4VH gene differed E
`18 nucleotides from that of the HIGI gene and the nucleotir
`differences were found equally in hypervariable regions ar
`framework regions. The sequences of the 5’ flanking region 4
`the 3C4VH gene were also highly homologous to that of ti
`HIGI gene. These data indicated that the V" gene of the H6-3C
`hybridoma and HIGI gene belonged to the same VH ger
`family. The deduced amino acid sequences of the 3C4VH get
`showed the 73% homology with a human myeloma protei:
`WAH (Takahashi er al., 1982), which was classified as a huma
`heavy chain variable region subgroup II (Kabat et al., 1983
`Since members of the same heavy chain subgroup share the 70‘
`or greater homology in amino acid sequence (Dayhoff, 1972
`the 3C4VH is a member of subgroup II. The D region of tl
`3C4VH gene was composed of 28 nucleotides coding nine amin
`acids. The sequence of the D region showed no homology to th:
`of HIG1 or any known human germ line D regions (Siebenlist.
`al., 1981; Wu & Kabat, 1982), suggesting that it was a novel
`region. The JH gene segment of the 3C4VH gene was J6 (Revetc
`et al., 1981) and it was the same as the case of HIGI gene (Kuc
`et aI., l98S).
`The nucleotide sequence of 3C4L2 coding for the }.-chain 1
`the H6-3C4 hybridoma was also determined (Fig. 2b). Tl
`deduced amino sequences of the 3C4VL gene showed the 87‘
`homology with the V region of SH protein (Titani et al., 1970),
`member of subgroup IV(Yamasaki, Komori & Watanab
`1987). Northern blot analysis with the 3C4VH gene and tr
`3C4L2 variable region as probes showed the 2-8 kb and 1-8 k
`
`r.
`
`3!
`
`[cl
`
`VI-4.
`
`VA
`
`Fig. 4. Northern blot analysis of H6-3C4, NS-l and four stable transfonnants (En34B3, En46A4, En46H 12 and E22Dl I). Total
`cytoplasmic RNA was electrophoresed on a fonnaldehyde agarose gel, transferred onto nitrocellulose filters and hybridized with the V
`region of (a) 3C4VH gene or (b) 3C4L2, as probes. (21) lanes 1 to 6 show a 24 h autoradiograph exposure. In panel (b) lane 1 shows a 24 h
`autoradiograph exposure, while lanes 2 to 6 show a 48 h autoradiograph exposure. Lane 1, H6-3C4; lane 2, NS-1; lane 3, En34B3; lane 4,
`En46A4; lane 5, En46Hl2; lane 6, E22Dl l.
`
`Genzyme Ex. 1043, pg 955
`
`Genzyme Ex. 1043, pg 955
`
`

`
`514
`
`Shinji Komori et al.
`
`hybridization bands with the H6-3C4 hybridoma RNA, respect-
`ively (data not shown). These data indicated that both heavy
`and light chain genes isolated from the H6-3C4 hybridoma were
`functional rearranged genes.
`
`Construction ofnovel human immunoglobulin genes and introduc-
`tion into mouse myeloma cells
`The isolated VH region fragment (EcoRI-Mlul, 1-85 kb, Fig. 1)
`of the 3C4 heavy-chain gene (3C4VH) was ligated to the human
`Cy, gene (Mlul-BamHI, 13 kb) (Kudo et al., 1985), and was
`inserted into EcoRI-BamHI site of pSV2gpt vector, resulting in
`the plasmid pSV2-SIG]
`(Fig. 3a). The Cy. gene fragment
`contained a human heavy chain enhancer region. The cloned
`3C4 /l-light chain gene (3C4L2) fragment (HincII-HindIII, 4-6
`kb, Fig.
`l) was first ligated to a human heavy chain gene
`enhancer region (MluI-Hpal fragment,
`1 kb), and then, after
`linker conversion, inserted into EcoRI site of pSV2neo vector.
`The resultant plasmid was designated as pSV2-SI/I-E (Fig. 3b).
`The plasmid containing the class-switched heavy chain gene was
`introduced into mouse myeloma cells, X63Ag8.653, by proto-
`plast fusion. Several stable transformants were obtained after
`selection with mycophenolic acid. The plasmid containing the
`cloned 3C4 light chain gene with a human heavy chain enhancer
`region was transfected into the above transformants producing
`the class-switched heavy chain gene products. After selection
`
`with G418 antibiotics, the stable transformants containing the
`class-switched heavy chain gene and the cloned 3C4 light chain
`gene were established.
`
`DNA and RNA blot analysis of the transformants
`Southern blot analysis of the DNA of the transformants was
`perfonned using human JH or human V 1. DNA as a probe. The
`results indicated that the introduced class-switched heavy chain
`and light chain genes were completely integrated without any
`deletion into the genomic DNA of mouse myeloma cells (data
`not shown). Transcripts of the introduced genes in the stable
`transfonnants were analysed by Northern blot analysis. As
`shown in Fig. 4a, a band of 1-8 kb in length, which was a
`secretory-type human yl transcript, was obtained with the RNA
`of each transfonnant when the 3C4VH DNA was used as a
`probe. The size of transcripts hybridized with the V region DNA
`of the 3C4L2 gene was the same as that of parental hybridoma
`H6-3C4 (Fig. 4b). The level of heavy chain gene expression of
`the transformants was similar to that of parental hybridoma,
`while the level of light chain gene expression was somewhat less,
`but still very high in the transformants except for clone E22Dl l.
`The transformant E22Dl 1, which is shown in lane 6 of Fig. 4b,
`produced very low amounts of mRNA for A-light chain. In case
`of E22D1 1, a heavy chain gene enhancer region was not ligated
`to the ).-light chain gene, but the other transformants, En34B3,
`
`|‘.'C-n - r {J uucec
`
`Housed
`
`Fig. 5. Analysis of the class-switched antibody by SDS-polyacrylamide gel electrophoresis. The supernatants of the transformants were
`electrophoresed on SDS-polyacrylamide gel in reduced or nonreduced condition. The proteins were transferred onto nitrocellulose
`filters by using a Bio Rad transblot apparatus. The filters (lane 1 to 3 and lane 1’ to 3’) were immunostained with peroxidase-conjugated
`anti-human yl heavy chain (E.Y. laboratories, Inc., USA) as described in Materials and Methods. The filters (land 4 to 6 and lane 4’ to
`6’) were immunostained with rabbit anti-human A light chain serum (Miles laboratories Inc. USA) and peroxidase-conjugated anti-
`rabbit IgG (ZYMED Laboratories Inc. USA) as described in Materials and Methods. Lanes 1, 4, En46Hl2: lanes 2, 5, En46A4; lanes 3,
`6, En34B3; lanes 1’, 4’, En46I-I12; lane 2’, 5’, En46A4; lane 3’, 6’, En34B3. The molecular weight of protein markers is shown in
`kilodaltons.
`
`Genzyme Ex. 1043, pg 956
`
`Genzyme Ex. 1043, pg 956
`
`

`
`A class-switched recombinant monoclonal antibody
`
`515
`
`Table 1. Sperm immobilizing activity of class-
`switched antibodies
`
`Motility of sperm (%)
`
`Complement
`
`Antibodies
`
`Not heated
`
`Heated
`
`H6 3C4
`En46A4
`En46H 12
`En34B3
`En34G5
`En3B7
`Nonnal human
`serum
`Control
`supernatant
`
`agglutinated
`87
`84
`85
`80
`80
`
`80
`
`80
`
`En46E4 and En46Hl2 possessed a heavy chain enhancer region
`ligated to the }.-light chain gene. These results suggested that a
`heavy chain enhancer region played a crucial role in the
`expression of }.-light chain gene in the present experiments.
`
`Analysis of the immunoglobulins secretedfrom the stable trans-
`formants by immunoblotting and micro SI test
`The immunoglobulins secreted from the stable transformants
`were assessed by immunoblotting of the proteins in the culture
`supernatants. The culture supernatants were electrophoresed on
`a SDS-polyacrylamide gel and the proteins were transferred to
`the nitrocellulose filters, followed by staining with peroxidase-
`conjugated anti-human y-chain or }.-chain antibodies. Under
`non-reducing conditions, all transformants secreted the com-
`plete form of human IgG molecules with a molecular weight of
`
`I00
`
`‘
`
`oro
`
`%inhibltion
`
`2
`
`64
`32
`I6
`8
`4
`Dilution of supernatant
`
`128 256 512
`
`Fig. 6. Spenn-immobilization test of the diluted supernatants of
`transfonnants. The supernatants of transformants were diluted with
`10% normal human serum. The spenn-immobilization test was per-
`formed as described in Materials and Methods. S150 titres of the
`supemantants of the transformants were in the ranges of 10-20. (0)
`En46A4; (A) En34B3; (E1) En34G5.
`
`160 kD (Fig. 5). Under reducing conditions, the 54 kD band of
`human y-chain and 25 kD band of human 1.-chain were
`observed. To examine the activity of antibody molecules
`produced by the transformants, a micro sperm-immobilization
`test (micro SI test) was performed (Isojima & Koyoma, 1976).
`The normal human sperm was incubated with the culture
`supernatants in the presence of a guinea-pig complement (Table
`1). The human spennatozoa were completely immobilized in the
`presence of complement. When the guinea pig complement was
`heat-inactivated at 56°C for 30 min, the spermatozoa were not
`immobilized. These results showed that
`the class-switched
`
`human IgG molecules secreted from the transformants fully
`retained the sperm-immobilizing activity of the parental hybri-
`doma 1-I6-3C4. The titres of sperm-immobilizing antibody of the
`culture supernatants of the transformants were in the range of
`10-20 S150 (Fig. 6) and that of parental hybridoma was 5,000
`S150. The lower immobilizing activity of the culture supernatants
`of the transformants may be accounted for by the facts that,
`first,
`the immunoglobulins produced by the human-mouse
`heterohybridoma H6-3C4 were IgM class, whereas the transfor-
`mants produced IgG class antibodies, which possess lower
`complement-dependent-immobilizing activity as compared
`with IgM class antibodies. But, IgG class anti-spenn antibodies
`are known to show the more potent sperm-immobilizing activity
`than IgM antibodies in the vaginal exudates because of the
`presence of Fc-binding proteins(Isojima et al., 1979; Jager et al.,
`1981). Secondly, the amounts of monoclonal antibodies se-
`creted from the transformants were about 0-2-0-5 ug/ml
`whereas the human-mouse heterohybridoma H6-3C4 secreted
`amounts of monoclonal antibodies 5-10 times higher. Affinity
`of the recombinant antibody appeared to be the same as that of
`the original monoclonal antibody.
`
`DISCUSSION
`
`A number of chimeric antibodies, which consist of mouse
`variable (V) region and human constant (C) region, have been
`constructed by a recombinant DNA technique (Morrison et al.,
`1984; Boulianne et al., 1984; Neuberger et a1., 1985; Sahagan et
`al., 1986; Nishimura et al., 1987). These chimeric antibodies
`were shown to retain antigen-binding activity similar to that of
`the parental mouse monoclonal antibodies (Boulianne et al.,
`1984; Neuberger et al., 1985; Sahagan et al., 1986; Nishimura et
`al., 1987). A rearranged V region gene can be joined to difierent
`constant region genes to produce the antibody molecules of
`different isotypes but with the same antigen specificity (class-
`switching). In the present study, we constructed the class-
`switched human IgG molecules which possessed the V region of
`human IgM antibody specific for human sperm-coating antigen.
`The rearranged heavy chain variable region (VDJH) gene was
`ligated to a human yl constant region gene containing a human
`heavy chain enhancer region. The resultant u to y, class-
`switched human antibody molecules retained the binding
`activity to human sperm-coating antigen and they showed the
`sperm-immobilizing activity in the presence of complement.
`These results demonstrated for the first time that the specificity
`of the V region was maintained after an artificial switch
`recombination. It is generally recognized that human-mouse
`heterohybridomas are unstable and will stop the antibody
`production by deletion of human chromosomes. Although the
`H6-3C4 heterohybridoma used in the present study was rather
`
`Genzyme Ex. 1043, pg 957
`
`Genzyme Ex. 1043, pg 957
`
`

`
`516
`
`Shinji Komori et al.
`
`stable and has retained antibody-producing activity for more
`than 1 year, human chromosomes in the hybridoma were
`gradually deleted during the culture. Moreover, it produced
`IgM class antibody. Since most of the anti-sperm antibodies
`found in the clinical cases are IgG antibodies, the IgM anti-
`sperm antibody of the heterohybridoma was class-switched to
`the IgG by the DNA recombinant technology. The stable
`transfonnants have constantly produced recombinant IgG
`antibodies for more than 6 months. The resultant IgG class
`antibody showed similar sperrn-immobilizing activity. We have
`previously reported the establishment of the transforrnants
`secreting the recombinant human-mouse chimeric monoclonal
`antibody (Nishimura et al., 1987) and these transformants also
`have been shown to produce antibody continuously for a long
`period. By applying recombinant DNA technology, we could
`continuously produce the intended human monoclonal anti-
`body molecules of the different immunoglobulin classes in the
`stable transforrnants. These recombinant antibodies may be
`useful for clinical trials.
`
`ACKNOWLEDGMENTS
`
`We thank Miss Y. Tsurusaki for help in preparing the manuscript. This
`work was supported in part by the grant from the Ministry of
`Education, Science and Culture of Japan.
`
`REFERENCES
`
`BANERJI, J., OLSON, L., & SCI-IAFFNER, W. (1983) A lymphocyte-specific
`cellular enhancer is located down stream of the joining region in
`immunoglobulin heavy chain genes. Cell 38, 729.
`BOULIANNE, G.L., HozUMI, N. & SI-IULMAN, M.J. (1984) Production of
`functional chimeric mouse/human antibody. Nature 312, 643.
`DAYHOI-‘F, M.O. (1972) Atlas of Protein Sequence and Structure. Vol 5,
`p.229. National Biomedical Research Foundation, Washington DC.
`GILLIES, S.D., MoRRIsoN, S.L., OI, V.T. & ToNEGAwA, S. (1983) A
`tissue-specific transcription enhancer element is located in the major
`intron of a rearranged immunoglobulin heavy chain gene. Cell 38,
`717.
`
`lsoJIMA, S., LI, T.S. & ASHITAKA, Y. (I968) Immunological analysis of
`spemi immobilizing factor found in sera of women with unexplained
`sterility. Am. J. Obstel. Gynecol. 101, 677.
`ls0JIMA, S. & KOYAMA, K. ([976) Quantitative estimation of sperm
`immobilizing antibody in the sera of women with sterility of unknown
`etiology:
`the 50% sperm immobilization unit
`(S150).
`In: Recent
`Advances in Human Reproduction (ed. A. Campos da Paz, V.A. Drill,
`H. Hayashi, W. Rodrigues & A.V. Schally) p.10. Excerpta Medica,
`Amsterdam.
`IsoJIMA, S. & KOYAMA, K. (1979) Microtechnique of sperm immobiliza-
`tion test. In: Immunology of Reproduction (ed. K. Bratanov, V.H.
`Valchanov, V. Dikov, R. Georgieva & B. Somlev) p.215. Bulgarian
`Academy of Science, Sofia.
`ISOJIMA, S., KOYAMA, K., IKUMA, K. & KUBo'rA, K. (1979) Effect of
`antisperm antibodies on sperm migration through cervical mucusflnz
`International Congress Series, Gynecology and Obstetrics. (ed. S.
`Sakamoto, S. Tojo & T. Nakayama) Vol. 5l2, p.705. Excerpta
`Medica, Amsterdam.
`ISOJIMA, S., KAMEDA, K., Tsun, Y., SHIGETA, M., IKEDA, Y. & KOYAMA,
`K. (I987) Establishment and characterization of human hybridoma
`secreting the monoclonal antibody with a high titers of sperm
`immobilizing and agglutinating activities against human seminal
`plasma. J. Reprod. Immunol. 10, 67.
`JAGER, S., KREMER, J., KUIKEN, J. & MULDER, 1. (1981) The significance
`of the Fc part of antisperrnatozoal antibodies for the shaking
`
`phenomenon in the sperrn-cervical mucus contact test. Fertil. Steril.
`36, 792.
`KABAT, E.A., WU, T.T., BIIDI-‘SKY, H., REID-MILLER, M. & PERRY, H.,
`(1983) In: Sequences of Proteins of Immunological Interest. p. 109.
`National Institutes of Health, Bethesda.
`KEARNEY, J.F., RADBRUCH, A., LIEsEoANG, B. & RAJEWSKY, K. (I979) A
`new mouse myeloma cell
`line that has lost immunoglobulin ex-
`pression but permits the construction of antibody-secreting hybrid
`cell lines. J. Immunol. 123, I548.
`KUDO, A., IsnInARA, T., Nrsr-IIMURA, Y. & WATANAEE, T. (1985) A
`cloned human immunoglobulin heavy chain gene with a novel direct-
`repeat sequence in 5’ flanking region. Gene 33, ISI.
`MoRRrsoN, S.L., JOHNSON, M.J., HERZENEERG, L.A. & OI, V.T. (1984)
`Chimeric human antibody molecules: mouse antigen-binding
`domains with human constant region domains. J. Immunol. 81, 6851.
`MULLIGAN, R.C. & BERG, P. (1981) Selection for animal cells that
`express the Escherichia coli gene coding for xanthine-guanine phos-
`phoribosyltransferase. Proc. natn Acad. Sci.

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket